CIK 0001818331
- Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851966622
- Phone
- +1 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise | +18,750 | 75,257 | ||
| 2024-03-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Unit | −18,750 | 225,000 | ||
| 2024-03-16 | Saad Kareem CHIEF TRANSFORMATION OFFICER | Option exercise | +5,114 | 31,525 | ||
| 2024-03-16 | Saad Kareem CHIEF TRANSFORMATION OFFICER | Option exercise · Restricted Stock Unit | −5,114 | 61,362 | ||
| 2024-03-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +7,197 | 32,180 | ||
| 2024-03-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −7,197 | 86,363 | ||
| 2024-03-12 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −931 | $9.21 | $9K | 24,983 |
| 2024-03-12 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −2,618 | $9.21 | $24K | 56,507 |
| 2024-03-12 | Saad Kareem CHIEF TRANSFORMATION OFFICER | Sale | −897 | $9.21 | $8K | 26,411 |
| 2024-03-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +2,462 | 25,914 | ||
| 2024-03-09 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −2,462 | 27,083 | ||
| 2024-03-09 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise | +6,547 | 59,125 | ||
| 2024-03-09 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Unit | −6,547 | 72,011 | ||
| 2024-03-09 | Saad Kareem CHIEF TRANSFORMATION OFFICER | Option exercise | +2,841 | 27,308 | ||
| 2024-03-09 | Saad Kareem CHIEF TRANSFORMATION OFFICER | Option exercise · Restricted Stock Unit | −2,841 | 31,249 | ||
| 2024-03-05 | Casdin Capital, LLC Director | Purchase | +900 | $8.83 | $8K | 2,703,509 |
| 2024-03-04 | Casdin Capital, LLC Director | Purchase | +40,000 | $8.74 | $350K | 2,702,609 |
| 2024-03-04 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −301 | $8.57 | $3K | 23,452 |
| 2024-03-01 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +718 | 23,753 | ||
| 2024-03-01 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −718 | 7,173 |
Page 31 of 36 · 718 trades